Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kaplancikli ZA"" wg kryterium: Autor


Tytuł:
Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as possible anticancer agents
Autorzy:
Çevik Ulviye Acar
Osmaniye Derya
Levent Serkan
Sağlik Begüm Nurpelin
Çavuşoğlu Betül Kaya
Karaduman Abdullah Burak
Özkay Yusuf
Kaplancikli Zafer Asim
Pokaż więcej
Temat:
4-thiadiazole
anticancer activity
aromatase inhibitory activity
mtt assay
Pharmaceutical industry
HD9665-9675
Źródło:
Acta Pharmaceutica, Vol 70, Iss 4, Pp 499-513 (2020)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/1846-9558
Dostęp URL:
https://doaj.org/article/0297ca8d7ca049128a13d18cc4e1efe5  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
The 4-(dimethylaminoalkyl)piperazine inhibitors of α-glucosidase: allosteric enzyme inhibition and identification of interacting chemical groups.
Autorzy:
Ghani U; Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ashraf S; Dr. Panjwani Center for Molecular Medicine & Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Ul Haq Z; Dr. Panjwani Center for Molecular Medicine & Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Kaplancikli ZA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Demirci F; Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Özkay Y; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Afzal S; Biomedical Research Laboratory, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Turkish journal of chemistry [Turk J Chem] 2022 May 20; Vol. 46 (5), pp. 1484-1492. Date of Electronic Publication: 2022 May 20 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Dithiocarbamate derivatives inhibit α-glucosidase through an apparent allosteric site on the enzyme.
Autorzy:
Ghani U; Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ashraf S; Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Ul-Haq Z; Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Mujamammi AH; Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Özkay Y; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Demirci F; Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.; Faculty of Pharmacy, Eastern Mediterranean University, Mersin, Turkey.
Kaplancikli ZA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2021 Aug; Vol. 98 (2), pp. 283-294. Date of Electronic Publication: 2021 Jun 19.
Typ publikacji:
Journal Article
MeSH Terms:
Glycoside Hydrolase Inhibitors/*chemistry
Thiocarbamates/*chemistry
alpha-Glucosidases/*chemistry
Allosteric Site ; Binding Sites ; Catalytic Domain ; Diabetes Mellitus/drug therapy ; Glycoside Hydrolase Inhibitors/metabolism ; Glycoside Hydrolase Inhibitors/therapeutic use ; Humans ; Hypoglycemic Agents/chemistry ; Hypoglycemic Agents/metabolism ; Hypoglycemic Agents/therapeutic use ; Kinetics ; Molecular Docking Simulation ; Structure-Activity Relationship ; Thiocarbamates/metabolism ; alpha-Glucosidases/metabolism
Czasopismo naukowe
Tytuł:
Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives.
Autorzy:
Acar Cevik U; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Saglik BN; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Levent S; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Osmaniye D; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Kaya Cavuşoglu B; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Ozkay Y; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Kaplancikli ZA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26210 Eskişehir, Turkey. .
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2019 Feb 28; Vol. 24 (5). Date of Electronic Publication: 2019 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Acetylcholinesterase*/chemistry
Cholinesterase Inhibitors*/chemical synthesis
Cholinesterase Inhibitors*/chemistry
Molecular Docking Simulation*
Butyrylcholinesterase/*chemistry
GPI-Linked Proteins/antagonists & inhibitors ; GPI-Linked Proteins/chemistry ; Humans ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.
Autorzy:
Kaya B; a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.
Yurttaş L; a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.
Sağlik BN; a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.; b Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.
Levent S; a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.; b Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.
Özkay Y; a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.; b Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.
Kaplancikli ZA; a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2017 Dec; Vol. 32 (1), pp. 193-202.
Typ publikacji:
Journal Article
MeSH Terms:
Monoamine Oxidase Inhibitors/*pharmacology
Piperazines/*pharmacology
Kinetics ; Molecular Docking Simulation ; Monoamine Oxidase/metabolism ; Monoamine Oxidase Inhibitors/chemistry ; Piperazines/chemistry ; Spectrum Analysis/methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies